{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:57:18Z","timestamp":1788926238066,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QH571"],"award-info":[{"award-number":["ZR2023QH571"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2021MH353"],"award-info":[{"award-number":["ZR2021MH353"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22202120"],"award-info":[{"award-number":["22202120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.mtbio.2025.102233","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T06:38:18Z","timestamp":1755931098000},"page":"102233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Engineered biomimetic vesicles induce cuproptosis and disrupt efferocytosis for metastatic adenoid cystic carcinoma immunotherapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Mingyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-6881","authenticated-orcid":false,"given":"Xiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.102233_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.14639\/0392-100X-N1729","article-title":"Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis","volume":"41","author":"Cantu","year":"2021","journal-title":"Acta Otorhinolaryngo"},{"key":"10.1016\/j.mtbio.2025.102233_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.14639\/0392-100X-N1379","article-title":"Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis","volume":"41","author":"Cantu","year":"2021","journal-title":"Acta Otorhinolaryngo"},{"key":"10.1016\/j.mtbio.2025.102233_bib3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.21873\/anticanres.16929","article-title":"Adenoid cystic carcinoma, clinical presentation, current treatment and approaches towards novel therapies","volume":"44","author":"Zupancic","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mtbio.2025.102233_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105945","article-title":"Current opinions on diagnosis and treatment of adenoid cystic carcinoma","volume":"130","author":"Fang","year":"2022","journal-title":"Oral Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11912-022-01233-z","article-title":"Treatment of recurrent or metastatic adenoid cystic carcinoma","volume":"24","author":"de Sousa","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.mtbio.2025.102233_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11864-022-01001-y","article-title":"Metastatic adenoid cystic carcinoma: genomic landscape and emerging treatments","volume":"23","author":"de Sousa","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck--An update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.mtbio.2025.102233_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122223","article-title":"Copper homeostasis and cuproptosis in mitochondria","volume":"334","author":"Tian","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.mtbio.2025.102233_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2025.102233_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/imr.13276","article-title":"Copper homeostasis and cuproptosis in cancer immunity and therapy","volume":"321","author":"Liu","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.mtbio.2025.102233_bib13","article-title":"Redox homeostasis disruptors based on metal-phenolic network nanoparticles for chemo\/chemodynamic synergistic tumor therapy through activating apoptosis and cuproptosis","volume":"12","author":"Zhao","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.102233_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404971","article-title":"Glutathione-scavenging celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy","volume":"36","author":"Lu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102233_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123201","article-title":"Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system","volume":"319","author":"Li","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102233_bib16","article-title":"Copper-based composites nanoparticles improve triple-negative breast cancer treatment with induction of apoptosis-cuproptosis and immune activation","volume":"13","author":"Wang","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.102233_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2025.102233_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.102233_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s43018-024-00731-2","article-title":"Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","volume":"5","author":"Astuti","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2025.102233_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115540","article-title":"Efferocytosis: an accomplice of cancer immune escape","volume":"167","author":"Qiu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2025.102233_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","volume":"11","author":"Lin","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.mtbio.2025.102233_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","article-title":"Efferocytosis in the tumor microenvironment","volume":"40","author":"Werfel","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.mtbio.2025.102233_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-020-00542-9","article-title":"Regulation of efferocytosis as a novel cancer therapy","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.mtbio.2025.102233_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102763","article-title":"NOX2 inhibition stabilizes vulnerable plaques by enhancing macrophage efferocytosis via MertK\/PI3K\/AKT pathway","volume":"64","author":"Wang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.mtbio.2025.102233_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12032-023-02153-z","article-title":"Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer","volume":"40","author":"Myers","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib26","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","article-title":"CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer","volume":"15","author":"Cheng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102233_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.ircmb.2021.02.002","article-title":"Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment","volume":"361","author":"Zhou","year":"2021","journal-title":"Int. Rev. Cel. Mol. Bio."},{"key":"10.1016\/j.mtbio.2025.102233_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/neuonc\/nox111","article-title":"MerTK as a therapeutic target in glioblastoma","volume":"20","author":"Wu","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.mtbio.2025.102233_bib29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41467-023-37369-0","article-title":"Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity","volume":"14","author":"Zhuang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102233_bib30","doi-asserted-by":"crossref","first-page":"18089","DOI":"10.1021\/acsnano.3c04884","article-title":"Efferocytosis nanoinhibitors to promote secondary necrosis and potentiate the immunogenicity of conventional cancer therapies for improved therapeutic benefits","volume":"17","author":"Wu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102233_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120894","article-title":"Delivery of manganese carbonyl to the tumor microenvironment using Tumor-Derived exosomes for cancer gas therapy and low dose radiotherapy","volume":"274","author":"Zhu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102233_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.actbio.2022.10.018","article-title":"Glucose oxidase-amplified CO generation for synergistic anticancer therapy via manganese carbonyl-caged MOFs","volume":"154","author":"Wang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.102233_bib33","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1021\/acs.nanolett.3c01008","article-title":"Nanodrug augmenting antitumor immunity for enhanced TNBC therapy via pyroptosis and cGAS-STING activation","volume":"23","author":"Zhong","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.102233_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409661","article-title":"Microenvironment-activatable probe for precise NIR-II monitoring and synergistic immunotherapy in rheumatoid arthritis","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102233_bib35","article-title":"H2O2-triggered CO release based on porphyrinic covalent organic polymers for photodynamic\/gas synergistic therapy","volume":"60","author":"Wang","year":"2024","journal-title":"Chem. Commun."},{"key":"10.1016\/j.mtbio.2025.102233_bib36","first-page":"110808","article-title":"Pillar[5]arene based prodrug as a GSH-responsive SO2 nanogenerator for effective gas cancer therapy","author":"Wu","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.mtbio.2025.102233_bib37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2025.102233_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109304","article-title":"Targeting STING for cancer immunotherapy: from mechanisms to translation","volume":"113","author":"Huang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mtbio.2025.102233_bib39","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mtbio.2025.102233_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mtbio.2025.102233_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJN.S442877","article-title":"Biomimetic nano-drug delivery system: an emerging platform for promoting tumor treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102233_bib42","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41401-024-01355-z","article-title":"Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy","volume":"45","author":"Zeng","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.mtbio.2025.102233_bib43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2174\/1389450122666210114095859","article-title":"Biomimetic drug delivery systems oriented by biological function in tumor targeting","volume":"22","author":"Wang","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.mtbio.2025.102233_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122770","article-title":"Cell membrane biomimetic nano-delivery systems for cancer therapy","volume":"15","author":"Xia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102233_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.102233_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000174","article-title":"Cell membrane coated particles","volume":"4","author":"Spanjers","year":"2020","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.mtbio.2025.102233_bib47","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/acsnano.0c01665","article-title":"Cell-membrane-mimicking nanodecoys against infectious diseases","volume":"14","author":"Rao","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102233_bib48","article-title":"Cell membrane-derived vesicle: a novel vehicle for cancer immunotherapy","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.102233_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121163","article-title":"Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma","volume":"278","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102233_bib50","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1021\/jacs.4c18400","article-title":"Dual pathways of photorelease carbon monoxide via photosensitization for tumor treatment","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2025.102233_bib51","article-title":"SOD2 deregulation enhances migration, invasion and has poor prognosis in salivary adenoid cystic carcinoma","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep. UK"},{"key":"10.1016\/j.mtbio.2025.102233_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107577","article-title":"MERTK in cancer therapy: targeting the receptor tyrosine kinase in tumor cells and the immune system","volume":"213","author":"Huelse","year":"2020","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.mtbio.2025.102233_bib53","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1158\/1078-0432.CCR-12-1451","article-title":"Molecular pathways: MERTK signaling in cancer","volume":"19","author":"Cummings","year":"2013","journal-title":"Clin. Cancer Res."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425008038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425008038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:30:40Z","timestamp":1772915440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425008038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"alternative-id":["S2590006425008038"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102233","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered biomimetic vesicles induce cuproptosis and disrupt efferocytosis for metastatic adenoid cystic carcinoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102233"}}